Institution

Skåne University Hospital

Lund, SwedenWebsite

Also known as: Skånes universitetssjukhus · SUS

132running trials
47closed trials
50,349publications (OpenAlex)

Running trials

Not yet recruiting
Standalone Thoracoscopic Left Atrial Appendage Closure Versus Medical Therapy in Atrial Fibrillation
NCT07705282· Region Skane· Source
Not yet recruiting
Real-World Data Collection of GORE Devices Used In the Endovascular Treatment of Aortic Aneurysms Which Incorporate Visceral Arteries.
NCT07480395· W.L.Gore & Associates· Source
Not yet recruiting
Prophylactic Treatment of Graves Ophthalmopathy (GO) in Newly Diagnosed Graves' Disease (GD) With Atorvastatin (ATORGO)
NCT07883356· Phase 2· Region Skane· Source
Recruiting
Effects of Microelectrode-based Brain Stimulation in Humans
NCT07820189· Lund University· Source
Recruiting
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
NCT07871864· Phase 3· Gustave Roussy, Cancer Campus, Grand Paris· Source
Recruiting
The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial
NCT07442357· Copenhagen University Hospital, Rigshospitalet· Source
Recruiting
A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active conventional therapy versus three biologic treatments, and two de-escalation strategies in patients who respond to treatment.
NCT01491815· Phase 4· Karolinska Institutet· Source
Not yet recruiting
Prospective Longitudinal Study of Sleep, Brain Activity, and Plasma Analyses in Patients Undergoing Epilepsy Surgery
NCT07885826· Region Skane· Source
Not yet recruiting
REcovery After Cancer Application
NCT07642492· Karolinska Institutet· Source
Recruiting
A Multi-site, Prospective, Non-interventional, Observational Data Collection Study in Patients Undergoing a Right Heart Catheterization
NCT07010562· Acorai AB· Source
Recruiting
Fight Osteosarcoma Through European Research evolving study platform from diagnosis to relapse (FOSTER evolving study platform)
2023-505575-69-01· Phase 3· Institut Gustave Roussy· Source
Active, not recruiting
Personalizing Chemotherapy Selection After Surgery for Patients With Stage III Colorectal Cancer Using a Blood Test
NCT07340567· Phase 3· UNICANCER· Source
Recruiting
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
NCT07589634· Phase 2· Janssen Research & Development, LLC· Source
Recruiting
A 12-Week Study of Flexilev With the OraFID Device and App in Parkinson's Patients
NCT07839793· Phase 4· Navamedic AB· Source
Recruiting
Multicenter Study for External Validation of the TB-NET Score
NCT07903532· Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz· Source
Recruiting
Uneven Nutrition and Life Style as IBD Triggers in Adolescents and Adults
NCT07389161· Region Skane· Source
Recruiting
Non-Invasive Hemodynamic Monitoring in Hospitalized Heart Failure
NCT07671742· Acorai AB· Source
Recruiting
Sleep and Stroke Rehabilitation Study
NCT07579871· Malin Eleonora av Kák Gustafsson, MD, PhD· Source
Recruiting
Fusion Imaging in Endovascular Thrombectomy for Acute Ischemic Stroke
NCT06975696· Region Skane· Source
Recruiting
Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery
NCT07351149· Uppsala University· Source
Not yet recruiting
Rituximab as therapy for autoantibody mediated fibromyalgia (RAFT) - proof of concept
2025-523465-21-00· Phase 3· Region Stockholm – SLSO· Source
Not yet recruiting
Increased Pacemaker Lower Rate in ATTR Cardiac Amyloidosis
NCT07413081· Region Skane· Source
Recruiting
Sucrase-Isomaltase (SI) Genes and Meal Load
NCT07309601· Region Skane· Source
Recruiting
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
NCT07222137· Phase 3· Eli Lilly and Company· Source
Recruiting
Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not
NCT07273409· Uppsala University· Source
Recruiting
Single-Stapled Technique for Colorectal Anastomosis
NCT07417358· Umeå University· Source
Recruiting
Evaluation of Three Tests to Assess Social Cognition in Huntington Disease
NCT07253038· Region Skane· Source
Recruiting
Intraperitoneal Paclitaxel and Systemic Therapy Versus Systemic Therapy Alone in Gastric Cancer Patients With Peritoneal Metastasis
NCT07304271· Phase 3· Magnus Nilsson· Source
Recruiting
Optimized Expansion of the Implanted Transcatheter Aortic Valve
NCT07042529· Ole De Backer· Source
Recruiting
Late-Onset Seizures: Trial of Vascular Risk Investigation and Treatment
NCT07116330· Sahlgrenska University Hospital· Source
Recruiting
Preventing postoperative complications in patients undergoing high-risk pancreatoduodenectomy with a bundle approach including hydrocortisone, ocreotide, and teres ligament patch (PANENCA): an international randomized controlled multicenter trial
2024-519667-18-00· Phase 4· Amsterdam UMC Stichting· Source
Recruiting
SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma
NCT06794775· Phase 3· Hildur Helgadottir· Source
Active, not recruiting
A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy
NCT06821542· Phase 3· Incyte Corporation· Source
Recruiting
Evaluation of Clinical Outcomes of Ponto Procedures Performed in Settings Outside the Main Operating Room (i.e. Out-of-OR)
NCT06930781· Oticon Medical· Source
Recruiting
Reperfusion Treatment in Acute Pulmonary Embolism
NCT07003646· Sahlgrenska University Hospital· Source
Recruiting
Treatment With Auricular Vagus Nerve Stimulation in Rheumatoid Arthritis - the TRAVAGA Study
NCT06779123· taVNS AB· Source
Recruiting
Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease
NCT06882993· Esbjerg Hospital - University Hospital of Southern Denmark· Source
Active, not recruiting
Post Market Registry for GORE® TAG® Thoracic Branch Endoprosthesis
NCT06507865· W.L.Gore & Associates· Source
Active, not recruiting
REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure
NCT06557798· The Leeds Teaching Hospitals NHS Trust· Source
Recruiting
Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
NCT06419946· Phase 3· Vastra Gotaland Region· Source
Enrolling by invitation
The Skin Microbiota in Skin Disease and Eczema
NCT06924333· Region Skane· Source
Recruiting
International Care Bundle Evaluation in Cerebral Hemorrhage Research
NCT06429332· Phase 4· Region Skane· Source
Recruiting
An International Multicenter Study on Transcatheter Device Closure of Perimembranous Ventricular Septal Defects
NCT06823635· Fondation Hôpital Saint-Joseph· Source
Enrolling by invitation
Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases
NCT06763783· Phase 4· Region Skane· Source
Recruiting
Breath-holding Spells and Its Management Study
NCT06628271· Region Skane· Source
Recruiting
Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses
NCT06578234· Phase 4· Region Skane· Source
Recruiting
Effect of Salovum® on Pressure, Oxygen and Inflammation in Glioblastoma
NCT07364786· Phase 2· Peter Siesjö· Source
Recruiting
European Registry of Next Generation Imaging in Advanced Prostate Cancer
NCT06866782· Fundacio Puigvert· Source
Recruiting
Stroke Alarm Efficacy Trial
NCT06315192· Region Skane· Source
Recruiting
Selective Defunctioning Stoma in Low Anterior Resection for Rectal Cancer
NCT06214988· Skane University Hospital· Source

Showing 50 of 132.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Childhood cancers9 recruiting
Prostate cancer7 recruiting
Gastric and oesophageal cancer5 recruiting
Heart failure5 recruiting
Stroke5 recruiting
Colorectal cancer4 recruiting
Lung cancer4 recruiting
Melanoma4 recruiting
Aortic stenosis3 recruiting
Atrial fibrillation3 recruiting
Coronary artery disease3 recruiting
Epilepsy3 recruiting
Glioblastoma3 recruiting
Neuroendocrine tumours3 recruiting
Pancreatic cancer3 recruiting
Parkinson disease3 recruiting
Rheumatoid arthritis3 recruiting
Sarcoma3 recruiting
Acute myeloid leukaemia2 recruiting
Alzheimer disease2 recruiting
Aortic aneurysm2 recruiting
Congenital heart disease2 recruiting
Crohn's disease2 recruiting
Iron deficiency anaemia2 recruiting
Lewy body dementia2 recruiting
Mild cognitive impairment2 recruiting
ALS (motor neurone disease)1 recruiting
Amyloidosis1 recruiting
Atopic dermatitis (eczema)1 recruiting
Chronic lymphocytic leukaemia1 recruiting
Chronic myeloid leukaemia1 recruiting
COPD1 recruiting
Deep vein thrombosis and pulmonary embolism1 recruiting
Essential tremor1 recruiting
Fibromyalgia1 recruiting
Frontotemporal dementia1 recruiting
Giant cell arteritis1 recruiting
Graves' disease1 recruiting
Haemophilia1 recruiting
Hepatitis B1 recruiting
Hepatitis C1 recruiting
HIV1 recruiting
Hodgkin lymphoma1 recruiting
Huntington's disease1 recruiting
Hyperparathyroidism1 recruiting
Insomnia1 recruiting
Irritable bowel syndrome1 recruiting
Multiple myeloma1 recruiting
Myelodysplastic syndromes1 recruiting
Myocarditis1 recruiting
Neuroblastoma1 recruiting
Osteoarthritis1 recruiting
Ovarian cancer1 recruiting
Peripheral artery disease1 recruiting
Polymyalgia rheumatica1 recruiting
Psoriasis1 recruiting
Psoriatic arthritis1 recruiting
Sarcoidosis1 recruiting
Spinal cord injury1 recruiting
Systemic sclerosis (scleroderma)1 recruiting
Tuberculosis1 recruiting
Type 1 diabetes1 recruiting
Type 2 diabetes1 recruiting
Ulcerative colitis1 recruiting
Vascular dementia1 recruiting

Closed trials

Completed
COMFI - a COMbined Fatigue Intervention
NCT06666452· The Danish Center for Expertise in Rheumatology· Source
Completed
VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS)
NCT06132568· Boston Scientific Corporation· Source
Completed
Introduction of EndoSign ® in Management of Barrett's Oesophagus - a Swedish Feasibility Study
NCT07036432· Vastra Gotaland Region· Source
Completed
Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)
NCT06122961· Novo Nordisk A/S· Source
Completed
Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD
NCT05819359· Phase 2· Bial R&D Investments, S.A.· Source
Terminated
A Prospective Study Evaluating Seroprevalence and Seroconversion of Antibodies Against Adeno-associated Virus (AAV)
NCT05580692· BioMarin Pharmaceutical· Source
Completed
Phase Ib/IIa Trial With AC01 in Patients With HFrEF
NCT05642507· Phase 1/2· AnaCardio AB· Source
Terminated
Evaluating Safety and Biological Effect on Wound Healing of ILP100-Topical in Subjects With Diabetic Foot Ulcers
NCT05608187· Phase 2· Ilya Pharma· Source
Completed
A Clinical Study Evaluating Efficacy of Pirepemat on Falls Frequency in Patients With Parkinson's Disease (PD)
NCT05258071· Phase 2· Integrative Research Laboratories AB· Source
Terminated
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
NCT05310071· Phase 3· Biogen· Source
Completed
Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions
NCT05296122· Clinical Laserthermia Systems AB· Source
Completed
Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma
NCT05218499· Phase 2/3· Boehringer Ingelheim· Source
Completed
Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome
NCT05183178· Phase 4· Vastra Gotaland Region· Source
Completed
New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis
NCT05621343· Region Skane· Source
Completed
Perioperative Intravenous Lidocaine in Liver Surgery
NCT05153785· Phase 2/3· Lund University Hospital· Source
Completed
A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis
NCT05071664· Phase 2· Janssen Research & Development, LLC· Source
Completed
Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)
NCT05027074· Phase 2· Merck Sharp & Dohme LLC· Source
Terminated
Acute Hemodynamic Effects of Pacing the His Bundle in Heart Failure
NCT04701112· Region Skane· Source
Completed
Effectiveness of Treatment With Tofacitinib in Patients With Psoriatic Arthritis in Routine Clinical Practice
NCT04517669· Pfizer· Source
Terminated
Ultrasound-guided Venous Access for Pacemaker and Defibrillator Implants
NCT04867460· Region Skane· Source
Completed
CT-based 3D Planning, Computer Navigation and Subsequent Migration Analysis in Total Hip Arthroplasty
NCT05159206· Region Skane· Source
Completed
Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).
NCT04472429· Phase 3· Incyte Corporation· Source
Terminated
Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease
NCT04311567· Phase 4· Vastra Gotaland Region· Source
Completed
Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis
NCT04472598· Phase 3· AbbVie· Source
Terminated
His-pacing and AV-node Ablation vs. Pulmonary Vein Isolation for Atrial Fibrillation
NCT04512586· Region Skane· Source
Completed
A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)
NCT04447755· Phase 2· Merck Sharp & Dohme LLC· Source
Completed
Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease
NCT04379050· Phase 3· AbbVie· Source
Terminated
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205
NCT04241068· Phase 3· Biogen· Source
Completed
eHealth as an Aid for Facilitating and Supporting Self-management in Families With Long-term Childhood Illness
NCT04150120· Lund University· Source
Recruiting
A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
NCT03911128· Mats Heyman· Source
Completed
Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advance Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)
NCT03820986· Phase 3· Merck Sharp & Dohme LLC· Source
Completed
Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix
NCT03556839· Phase 3· Grupo Español de Investigación en Cáncer de Ovario· Source
Completed
Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer
NCT03353831· Phase 3· AGO Research GmbH· Source
Completed
A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)
NCT03587116· Phase 3· Pfizer· Source
Completed
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer
NCT03511664· Phase 3· Endocyte· Source
Completed
Aspirin in Colorectal Cancer Liver Metastases
NCT03326791· Phase 2/3· Oslo University Hospital· Source
Completed
A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma
NCT03277105· Phase 3· Janssen Research & Development, LLC· Source
Completed
Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001)
NCT03179436· Phase 1/2· Merck Sharp & Dohme LLC· Source
Completed
Corneal Crosslinking Treatment Study
NCT04427956· Phase 4· Region Skane· Source
Completed
A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant
NCT03106324· Celgene· Source
Completed
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
NCT02914535· Phase 3· Alfasigma S.p.A.· Source
Completed
Ixazomib Rollover Study
NCT02924272· Phase 2· Takeda· Source
Completed
Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation
NCT02950051· Phase 3· German CLL Study Group· Source
Completed
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma
NCT02451943· Phase 3· Eli Lilly and Company· Source
Completed
Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma
NCT01909453· Phase 3· Pfizer· Source
Completed
RSA Study of Furlong Evolution With and Without Collar
NCT01894854· Region Skane· Source
Completed
Surgery for Primary Hyperparathyroidism (pHPT) in Patients Older Than 65 Years Compared With Follow-up
NCT01087619· Region Skane· Source

Registry name variants (80)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

Skåne University Hospital
Lund, 221 85
62 trials
Skåne University Hospital
Malmö, 205 02
40 trials
Skåne University Hospital Lund
Lund, 222 42
11 trials
Skanes universitetssjukhus
Lund, 221 85
10 trials
Skånes Universitetssjukhus Lund
Lund, Skåne Län [se-12] 22185
7 trials
Skånes universitetssjukhus Malmö
Malmö, 20502
6 trials
Skånes universitetssjukhus
Malmö, 211 46
3 trials
- NCT07116330Late-Onset Seizures: Trial of Vascular Risk Investigation and Treatment
  Contact: Petrea Frid
- NCT05071664A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis
- NCT04241068A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205
Department of Neurosurgery, Skane University Hospital
Lund, 221 85
2 trials
- NCT07364786Effect of Salovum® on Pressure, Oxygen and Inflammation in Glioblastoma
  Contact: Peter Siesjö, MD, PhD
- NCT05296122Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions
Department of Orthopedics, Skane University Hospital, Lund University
Lund, Skåne County 221 85
2 trials
- NCT05159206CT-based 3D Planning, Computer Navigation and Subsequent Migration Analysis in Total Hip Arthroplasty
- NCT01894854RSA Study of Furlong Evolution With and Without Collar
Region Skåne - Skåne University Hospital
Lund, 214 28
2 trials
- NCT06220435Tumor-directed Radiation Therapy for Patients With the Highest Risk Category of Localized Prostate Cancer
  Contact: Adalsteinn Gunnlaugsson, MD, PhD
- NCT05635409A Trial to Determine the Safety and Tolerability of Transplanted Stem Cell Derived Dopamine Neurons to the Brains of Individuals With Parkinson's Disease
Skåne University Hospital
Skåne, 20502
2 trials
- NCT06823635An International Multicenter Study on Transcatheter Device Closure of Perimembranous Ventricular Septal Defects
  Contact: Raymond N. Haddad, MD, MHSc, PhDc
- NCT02300766Cerebellar Mutism Syndrome Study
  Contact: Charlotte Castor
Barncancercentrum, avdelning 64, Skane University Hospital
Lund, SE- 221 85
1 trial
- NCT05477589Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML
  Contact: Kees-Jan Pronk, MD, PhD
Clinical Physiology, Department of Clinical Sciences Lund, Lund University, Skåne University Hospital
Lund
1 trial
- NCT06578234Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses
  Contact: Henrik Engblom, Professor, MD
Department of Cardiology, Skånes universitetssjukhus
Lund, 221 00
1 trial
- NCT03620266Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI
Department of dermatology, Skane University Hospital
Lund, 22185
1 trial
- NCT05033678Implementation of Teledermoscopy and Artificial Intelligence
  Contact: Asa Ingvar, PhD
Department of Endocrinology, Skåne University Hospital
Lund, 221 85
1 trial
- NCT05608187Evaluating Safety and Biological Effect on Wound Healing of ILP100-Topical in Subjects With Diabetic Foot Ulcers
Department of Oncology, Hematology and Radiophysics, Skane University Hospital
Lund, Skåne County 22241
1 trial
- NCT05755672On-treatment Biomarkers in Metastatic Colorectal Cancer for Life
  Contact: Jakob Eberhard, M.D. PhD.
Department of Ophthamology, Lund, Skåne University Hospital
Lund, 22185
1 trial
- NCT06379581Skin Cancer Diagnostics Using Photoacoustic Imaging
Department of Pain Pehabilitation, Skåne University Hospital
Lund, 22241
1 trial
- NCT05147948iACT for PTSD and Chronic Pain
  Contact: Sophia Åkerblom, PhD
Department of Pediatric Cardiology, Skane University Hospital
Lund
1 trial
- NCT05386173Effect of Fetal Aortic Valvuloplasty on Outcomes
  Contact: Petru Liuba
Dep. Cardiology, Skånes universitetssjukhus
Lund, 22185
1 trial
- NCT05183178Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome
Duplicate_Skane University Hospital Lund /ID# 220835
Lund, Skåne County 221 41
1 trial
- NCT04472598Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis
Duplicate_Skane University Hospital Lund /ID# 224747
Lund, Skåne County 221 41
1 trial
- NCT03844048An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
Lund University and Skåne University Hospital
Lund
1 trial
- NCT05150704MYTHS - MYocarditis THerapy With Steroids
  Contact: Oscar Braun, MD
Neonatal Department, Skåne University Hospital
Lund, Skåne County
1 trial
- NCT04150120eHealth as an Aid for Facilitating and Supporting Self-management in Families With Long-term Childhood Illness
Paediatric Cardiology Department, Skåne University Hospital
Lund, Skåne County
1 trial
- NCT04150120eHealth as an Aid for Facilitating and Supporting Self-management in Families With Long-term Childhood Illness
Paediatric Oncology Department, Skåne University Hospital
Lund, Skåne County
1 trial
- NCT04150120eHealth as an Aid for Facilitating and Supporting Self-management in Families With Long-term Childhood Illness
Paediatric Surgery Department, Skåne University Hospital
Lund, Skåne County
1 trial
- NCT04150120eHealth as an Aid for Facilitating and Supporting Self-management in Families With Long-term Childhood Illness
Respiratory medicine and allergy department, Skåne University Hospital
Lund
1 trial
- NCT06347939Mediastinal EBUS Cryobiopsy Study In Sweden
  Contact: Hamid Akbarshahi, MD, PhD
Section for Rheumatology, Skåne University Hospital, Lund
Lund, Skåne County SE 22185
1 trial
- NCT06779123Treatment With Auricular Vagus Nerve Stimulation in Rheumatoid Arthritis - the TRAVAGA Study
  Contact: Meliha C Kapetanovic, Professor
Skaenes Universitetssjukhus Lund
Lund, 22185
1 trial
- NCT04472429Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).
Skånes universitetssjukhus
Skåne
1 trial
- NCT07042529Optimized Expansion of the Implanted Transcatheter Aortic Valve
  Contact: Helle Søholm, MD, PhD
Skanes Universitetssjukhus Lund. (Site 0525)
Lund, Skåne County 221 85
1 trial
- NCT04447755A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)
Skanes Universitetssjukhus Lund. (Site 4601)
Lund, Skåne County 221 85
1 trial
- NCT03179436Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001)
Skånes Universitetssjukhus Malmö (Site 0454)
Malmö, Skåne County 205 02
1 trial
- NCT05027074Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)
Skanes Universitetssjukhus (Site 0213)
Lund, Skåne County 221 85
1 trial
- NCT03820986Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advance Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)
Skånes Universitetssjukhus, SUS
Lund, Skåne County
1 trial
- NCT07579871Sleep and Stroke Rehabilitation Study
  Contact: Malin E. a. K. Gustafsson, M.D., Ph.D.
Skanes Universitetssjukhus - Universitetssjukhuset I Lund
Lund, 221 85
1 trial
- NCT06821542A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy
Skane University Hospital - Barngatan, Clinical Trials Unit
Lund
1 trial
- NCT03511664Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer
Skåne University Hospital, Department of Rheumatology
Lund, Skåne County 20502
1 trial
- NCT04311567Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease
Skåne University Hospital, Department of Surgery, Lund
Lund, 22185
1 trial
- NCT01087619Surgery for Primary Hyperparathyroidism (pHPT) in Patients Older Than 65 Years Compared With Follow-up
Skåne University Hospital, Dept of Haematology
Lund, 22185
1 trial
- NCT03911128A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
  Contact: Trial Central Office
Skåne University Hospital, Dept. of Oncology
Lund, SE-226 52
1 trial
- NCT05387603Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors.
  Contact: Pernilla Asp, MD, Senior Consultant
Skåne University Hospital, Dept of Paediatrics
Lund, 22185
1 trial
- NCT03911128A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
  Contact: Trial Central Office
Skane University Hospital - Division of Neurology
Lund
1 trial
- NCT05258071A Clinical Study Evaluating Efficacy of Pirepemat on Falls Frequency in Patients With Parkinson's Disease (PD)
Skane University Hospital Lund /ID# 215385
Lund, Skåne County 224 84
1 trial
- NCT04379050Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease
Skane University Hospital Lund /ID# 220834
Lund, Skåne County 224 84
1 trial
- NCT04468984Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis
Skane University Hospital, Lund University
Lund, 221 85
1 trial
- NCT05819359Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD
Skåne University Hospital of Lund
Lund, Skåne County 22185
1 trial
- NCT05153785Perioperative Intravenous Lidocaine in Liver Surgery
Skåne University Hospital , oncology for adults
Lund
1 trial
- NCT07871864Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
  Contact: Marie AHLSTRÖM
Skåne University Hospital (pediatric)
Lund, 221 85
1 trial
- NCT04221035High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Skåne University Hospital, Region Skåne
Lund, 22184
1 trial
- NCT07253038Evaluation of Three Tests to Assess Social Cognition in Huntington Disease
  Contact: Isak Halling, MSc
Skåne University Hospital, section for rheumatology
Lund, SE-221 85
1 trial
- NCT06763783Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases
University Hospital of Skåne
Lund
1 trial
- NCT04300244Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma
Department of Hematology, Skåne University Hospital
Lund
Department of Oncology, Skåne University Hospital
Lund
Department of Pediatric Oncology, Skåne University Hospital
Lund
FO Kranskärl/Svikt, Skånes Universitetssjukhus
Lund
Hjärtavdelningen, Skånes Universitetssjukhus
Malmö, 20502
Skanes Universitetssjukhus, Hematoloaimottagningen
Lund, 22185
Skånes Universitetssjukhus - Lund - Barnhjärtcentrum
Lund, Skåne County 222 41
Skånes Universitetssjukhus - Lund - Barnnefroenheten
Lund, Skåne County 221 85
Skånes Universitetssjukhus - Lund - Lungmedicin
Lund, 221 85
Skånes Universitetssjukhus - Lund - Onkologens kliniska forskningsenhet
Lund, Skåne County 221 85
Skånes Universitetssjukhus Lund (Site 1901)
Lund, Skåne County 22185
Skånes Universitetssjukhus Lund (Site 2100)
Lund, Skåne County 22185
Skånes Universitetssjukhus Lund (Site 3000)
Lund, Skåne County 22185
Skanes Universitetssjukhus Lund (Site 3103)
Lund, Skåne County 22242
Skånes Universitetssjukhus Lund (Site 3201)
Lund, Skåne County 22185
Skånes Universitetssjukhus Lund (Site 3502)
Lund, Skåne County 22185
Skånes Universitetssjukhus Lund (Site 3702)
Lund, Skåne County 22185
Skånes Universitetssjukhus Lund (Site 5000)
Lund, Skåne County 22185
Skånes Universitetssjukhus Malmö (Site 0841)
Malmö, Skåne County 20502
Skånes Universitetssjukhus Malmö (Site 3802)
Malmö, Skåne County 20502
Skånes Universitetssjukhus - Malmö - Urologi
Malmö, Skåne County 214 28
Skane University Hospital, Dept. of Pediatrics, Section for Hematology and Oncology
Lund, 22185
Skane University Hospital - Lund, Department of Hematology and Vascular Disorders
Lund, 221 85
Skane University Hospital Lund /ID# 201244
Lund, Skåne County SE 221 41
Skane University Hospital Lund /ID# 227285
Lund, Skåne County 224 84
VO Akut- och internmedicin, Skånes Universitetssjukhus
Lund, 22185

Conditions

Diseases this institution publishes on or runs trials for.

Prostate cancer56 works · 10 trials
Lupus (SLE)29 works · 0 trials
Type 1 diabetes29 works · 1 trial
Coronary artery disease28 works · 9 trials
Mild cognitive impairment24 works · 2 trials
Congenital heart disease16 works · 3 trials
Endometriosis12 works · 0 trials
Neuroblastoma11 works · 1 trial
Childhood cancers11 works · 12 trials
Haemophilia10 works · 3 trials
Pulmonary arterial hypertension10 works · 0 trials
Psoriatic arthritis10 works · 4 trials
Huntington's disease9 works · 1 trial
Cerebral palsy8 works · 0 trials
Coeliac disease8 works · 0 trials
Epidermolysis bullosa7 works · 0 trials
Giant cell arteritis6 works · 1 trial
Irritable bowel syndrome6 works · 1 trial
Graves' disease5 works · 1 trial
Testicular cancer4 works · 0 trials
ANCA-associated vasculitis4 works · 0 trials
Vascular dementia4 works · 1 trial
Trigeminal neuralgia3 works · 0 trials
Restless legs syndrome3 works · 0 trials
Lichen planus3 works · 0 trials

Institution data: ROR 02z31g829 (CC0-1.0)Updated 14 Nov 2026

Report an error